QYL 769
Latest Information Update: 07 May 2003
Price :
$50 *
At a glance
- Originator Nonindustrial sources
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cytomegalovirus infections